Eli Lilly Q4 Adjusted EPS $2.49 Beats $2.19 Estimate, Sales $9.35B Beat $8.93B Estimate

Eli Lilly (NYSE:LLY) reported quarterly earnings of $2.49 per share which beat the analyst consensus estimate of $2.19 by 13.7 percent. This is a 19.14 percent increase over earnings of $2.09 per share from the same period last year. The company reported quarterly sales of $9.35 billion which beat the analyst consensus estimate of $8.93 billion by 4.74 percent. This is a 28.09 percent increase over sales of $7.30 billion the same period last year.

Scroll to Top